F

Franciscan Health | Indiana Blood and Marrow Transplantation

Research site

(Unclaimed)

Location

8111 S. Emerson Avenue Suite 207, Indianapolis, Indiana, United States of America

Site insights

Top conditions

Top treatments

Bosutinib

Ruxolitinib

INCB050465

Gemcitabine

methylprednisolone

Decitabine

tacrolimus

Ibrutinib

VRx-3996

IMPT-314

Parent organization

This site is a part of Franciscan Health

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 19 total trials

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL (EPCORE DLBCL-1)

The purpose of this trial is to find out if epcoritamab, also known as EPKINLY™ and GEN3013, is safe and works well as treatment for patients with di...

Active, not recruiting

Diffuse Large B-cell Lymphoma

Drug: Investigator's Choice Chemotherapy

Biological: Epcoritamab

A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) (topMIND)

The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...

Active, not recruiting

Chronic Lymphocytic Leukemia

Non Hodgkin Lymphoma

Drug: tafasitamab

Drug: parsaclisib

Study of IMPT-314 in R/R Aggressive B-cell NHL

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling

Relapsed Non-Hodgkin Lymphoma

Refractory Non-Hodgkin Lymphoma

Drug: IMPT-314